Both in Pharmaceuticals
Ligand Pharmaceuticals vs Oruka Therapeutics
Over the past year LGND returned +66.9% and ORKA returned +269.7%; their daily moves had a correlation of 0.28.
LGND +66.9% ORKA +269.7%Growth of $1, one year, split-adjusted
| Metric | LGND | ORKA |
|---|---|---|
| Price | $316.13 | $101.41 |
| Market cap | $6.32B | $6.71B |
| Today | +0.83% | +1.87% |
| 1 month | +6.5% | +26.5% |
| 6 months | +35.9% | +45.3% |
| Year to date | +67.2% | +234.6% |
| 1 year | +65.3% | +287.2% |
| Revenue growth (YoY) | −31.8% | — |
| Gross margin | 83.7% | — |
| Net margin | −36.2% | — |
| P/E (TTM) | 122.9× | — |
| Price / sales | 24.9× | — |
| Net cash | -$653.3M | $873.6M |
| Dividend yield | — | — |
| Volatility (60d) | 29.3% | 51.8% |
| Short % of float | 13.3% | 11.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).